A majority of patients with systemic lupus erythematosus achieve prolonged remission when treated with hydroxychloroquine at ...
A cohort study finds that hydroxychloroquine use in cutaneous lupus erythematosus reduces the risk of developing systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback